Search Results

The Optilite Hevylite IgA Kappa kit is a quantitative in vitro assay intended for the measurement of IgA Kappa (IgA heavy chain and Kappa light chain intact immunoglobulin) in serum using the Binding Site Optilite analyser. Measurement of Hevylite IgA Kappa is used alongside Hevylite IgA Lambda to calculate the IgA Lambda ratio. The Hevylite IgA Kappa / IgA Lambda ratio can be used when monitoring previously diagnosed IgA multiple myeloma patients and is used in conjunction with other laboratory tests and clinical evaluations. The assignment of complete response is reliant upon other tests including immunofixation, bone marrow and urine assessments.

The Optilite Hevylite IgA Lambda kit is a quantitative in vitro assay intended for the measurement of IgA heavy chain and Lambda light chain intact immunoglobulin) in serum using the Binding Site Optilite analyser. Measurement of Hevylite IgA Lambda is used alongside Hevylite IgA Kappa to calculate the IgA Lambda ratio. The Hevylite IgA Kappa / IgA Lambda ratio can be used when monitoring previously diagnosed IgA multiple myeloma patients and is used in conjunction with other laboratory tests and clinical evaluations. The assignment of complete response is reliant upon other tests including immunofixation, bone marrow and urine assessments.

Not Found

The provided document is a 510(k) clearance letter from the FDA for an in vitro diagnostic device, the Optilite Hevylite IgA Kappa Kit and Optilite Hevylite IgA Lambda Kit. It describes the intended use and regulatory classification, but it does not contain information about:

• Acceptance criteria and reported device performance (in the context of a study demonstrating it meets the criteria)
• Sample sizes for test sets, data provenance, training sets, or how ground truth was established for training sets
• Number/qualifications of experts or adjudication methods for ground truth
• MRMC comparative effectiveness studies or standalone algorithm performance

Therefore, I cannot populate the requested table or answer most of the questions based on the provided text.

The document states the Indications for Use of the device, which are:

• The Optilite Hevylite IgA Kappa kit is a quantitative in vitro assay intended for the measurement of IgA Kappa (IgA heavy chain and Kappa light chain intact immunoglobulin) in serum using the Binding Site Optilite analyser.
• The Optilite Hevylite IgA Lambda kit is a quantitative in vitro assay intended for the measurement of IgA Lambda (IgA heavy chain and Lambda light chain intact immunoglobulin) in serum using the Binding Site Optilite analyser.
• Measurement of Hevylite IgA Kappa is used alongside Hevylite IgA Lambda to calculate the IgA Kappa/IgA Lambda ratio. The Hevylite IgA Kappa / IgA Lambda ratio can be used when monitoring previously diagnosed IgA multiple myeloma patients and is used in conjunction with other laboratory tests and clinical evaluations.
• The assignment of complete response is reliant upon other tests including immunofixation, bone marrow and urine assessments.

This indicates the device's role in monitoring IgA multiple myeloma patients, but it does not specify performance metrics or the studies used to validate these claims.

Summary of unavailable information from the given text:

Ask a specific question about this device

Hevylite Human IgA Kappa is a quantitative in vitro assay performed on the Binding Site SPAPLUS for the measurement of IgA Kappa (IgA heavy chain and Kappa light chain intact immunoglobulin) in serum. Measurement of Hevylite Human IgA Kappa is used alongside Hevylite Human IgA Lambda to calculate the IgA Kappa / IgA Lambda ratio. The Hevylite Human IgA Kappa / IgA Lambda ratio can be used when monitoring previously diagnosed IgA multiple myeloma patients and is used in conjunction with other laboratory tests and clinical evaluations. The assignment of complete response is reliant upon other tests including immunofixation, bone marrow and urine assessments.

Hevylite Human IgA Lambda is a quantitative in vitro assay performed on The Binding Site SPAPLUS for the measurement of IgA Lambda (IgA heavy chain and Lambda light chain intact immunoglobulin) in serum. Measurement of Hevylite Human IgA Lambda is used alongside Hevylite Human IgA Kappa to calculate the IgA Kappa / IgA Lambda ratio. The Hevylite Human IgA Kappa / IgA Lambda ratio can be used when monitoring previously diagnosed IgA multiple myeloma patients and is used in conjunction with other laboratory tests and clinical evaluations. The assignment of complete response is reliant upon other tests including immunofixation, bone marrow and urine assessments.

Not Found

The provided text is a 510(k) premarket notification letter from the FDA, along with the device's Indications for Use. It describes a diagnostic device, the Hevylite Human IgA Kappa Kit and Hevylite Human IgA Lambda Kit, which are quantitative in vitro assays performed on the Binding Site SPAPLUS for measuring IgA Kappa and IgA Lambda in serum. These measurements are used to calculate the IgA Kappa/IgA Lambda ratio for monitoring previously diagnosed IgA multiple myeloma patients.

This document does not contain information about acceptance criteria, device performance, study details (sample size, data provenance, ground truth establishment, expert qualifications, adjudication methods), or comparative effectiveness studies. It primarily focuses on the regulatory aspects of the device's clearance.

Therefore, I cannot fulfill the request to describe the acceptance criteria and the study that proves the device meets them based solely on the provided text. The requested information is typically found in the accompanying technical documentation, such as the 510(k) summary or detailed clinical study reports, which are not present here.

Ask a specific question about this device

Hevylite Human IgA Kappa is a quantitative in vitro assay performed on the Siemens BN II nephelometer for the measurement of IgA Kappa (IgA heavy chain and Kappa light chain intact immunoglobulin) in serum. Measurement of Hevylite Human IgA Kappa is used alongside Hevylite Human IgA Lambda to calculate the JgA Kappa / IgA I levylite I luman IgA Kappa / IgA Lambda ratio can be used when monitoring previously diagnosed IgA multiple mycloma and is used in conjunction with other laboratory tests and clinical evaluations. The assignment of complete response is reliant upon other tests including immunotixation. bone marrow and urine assessments.

Hevylite Human IgA Lambda is a quantiative in vitro assy performed on the Siemens IN II nepheloment of IgA Lambda (IgA heavy chain and Lambda light chain intact immunoglobulin) in scrum. Mcasurement of Hevylite Human IgA Lambda is used alongside Hevylite Human IgA Kappa to calculate the IgA Lamburratio. The Hevylite Human IgA Kappa / 12A Lambda ratio can be used when monitoring previously diagnosed lgA multiple mycloma and is used in conjunction with other laboratory tests and clinical evaluations. The assignment of complete response is reliant upon other tests including immunofixation, bone marrow and urine assessments.

Not Found

This document is a 510(k) clearance letter from the FDA for two in-vitro diagnostic devices: the Hevylite™ Human IgA Kappa Kit and the Hevylite™ Human IgA Lambda Kit, both for use on Siemens BN™ II Systems. The letter states that the devices are substantially equivalent to legally marketed predicate devices.

The "Indications for Use" section on page 3 describes the purpose of these devices:

• Hevylite Human IgA Kappa is a quantitative in vitro assay for the measurement of IgA Kappa (IgA heavy chain and Kappa light chain intact immunoglobulin) in serum.
• Hevylite Human IgA Lambda is a quantitative in vitro assay for the measurement of IgA Lambda (IgA heavy chain and Lambda light chain intact immunoglobulin) in serum.

Both kits are used to calculate the IgA Kappa/IgA Lambda ratio or IgA Lambda/IgA Kappa ratio, respectively, for monitoring previously diagnosed IgA multiple myeloma, in conjunction with other laboratory tests and clinical evaluations. They are not to be used alone for the assignment of complete response, which requires other tests like immunofixation, bone marrow, and urine assessments.

While the document details the intended use and regulatory clearance, it does not contain the specific acceptance criteria for performance, nor does it describe a study proving the device meets acceptance criteria with the requested details (sample sizes, ground truth establishment, expert qualifications, etc.). This document confirms the device's clearance based on substantial equivalence, but it does not present the underlying performance study data.

Therefore, I cannot extract the information requested in your prompt regarding acceptance criteria and the study that proves the device meets them because that information is not provided in the supplied text. The document is an FDA clearance letter, not a detailed study report.

Ask a specific question about this device